Shire Plc. Price Target Raised to $148.00 at CRT Capital (SHPG)
Analysts at CRT Capital increased their target price on shares of Shire Plc. (NASDAQ:SHPG) from $135.00 to $148.00 in a research report issued to clients and investors on Friday, American Banking News.com reports. The firm currently has a “buy” rating on the stock. CRT Capital’s target price indicates a potential upside of 8.23% from the company’s current price.
Other equities research analysts have also recently issued reports about the stock. Analysts at Bank of America Corp. upgraded shares of Shire Plc. from a “neutral” rating to a “buy” rating in a research note to investors on Friday. Separately, analysts at RBC Capital raised their price target on shares of Shire Plc. from $114.00 to $122.00 in a research note to investors on Friday, October 18th. They now have a “sector perform” rating on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Shire Plc. in a research note to investors on Thursday, October 17th. They now have a $124.00 price target on the stock. Four analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $125.71.
Shire Plc. (NASDAQ:SHPG) traded down 1.81% during mid-day trading on Friday, hitting $134.26. The stock had a trading volume of 309,693 shares. Shire Plc. has a 1-year low of $81.76 and a 1-year high of $120.00. The stock’s 50-day moving average is $112.4 and its 200-day moving average is $99.10. The company has a market cap of $24.596 billion and a price-to-earnings ratio of 43.20.
Shire Plc. (NASDAQ:SHPG) last announced its earnings results on Thursday, October 24th. The company reported $1.77 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.65 by $0.12. The company had revenue of $1.24 billion for the quarter, compared to the consensus estimate of $1.23 billion. During the same quarter last year, the company posted $1.36 earnings per share. Shire Plc.’s revenue was up 12.5% compared to the same quarter last year.
Shire plc (NASDAQ:SHPG) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.